Annual revenue:
$48.30B+$3.29B(+7.32%)Summary
- As of today (April 14, 2025), BMY annual revenue is $48.30 billion, with the most recent change of +$3.29 billion (+7.32%) on December 1, 2024.
- During the last 3 years, BMY annual revenue has risen by +$1.92 billion (+4.13%).
- BMY annual revenue is now at all-time high.
Performance
BMY Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$12.34B+$450.00M(+3.78%)Summary
- As of today (April 14, 2025), BMY quarterly revenue is $12.34 billion, with the most recent change of +$450.00 million (+3.78%) on December 1, 2024.
- Over the past year, BMY quarterly revenue has increased by +$865.00 million (+7.54%).
- BMY quarterly revenue is now at all-time high.
Performance
BMY Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$48.30B+$865.00M(+1.82%)Summary
- As of today (April 14, 2025), BMY TTM revenue is $48.30 billion, with the most recent change of +$865.00 million (+1.82%) on December 1, 2024.
- Over the past year, BMY TTM revenue has increased by +$3.29 billion (+7.32%).
- BMY TTM revenue is now at all-time high.
Performance
BMY TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BMY Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.3% | +7.5% | +7.3% |
3 y3 years | +4.1% | +7.5% | +7.3% |
5 y5 years | +84.7% | +7.5% | +7.3% |
BMY Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +7.3% | at high | +12.6% | at high | +7.5% |
5 y | 5-year | at high | +84.7% | at high | +21.9% | at high | +55.8% |
alltime | all time | at high | +539.1% | at high | +642.6% | at high | +2456.2% |
Bristol-Myers Squibb Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $48.30B(+7.3%) | $12.34B(+3.8%) | $48.30B(+1.8%) |
Sep 2024 | - | $11.89B(-2.5%) | $47.44B(+2.0%) |
Jun 2024 | - | $12.20B(+2.8%) | $46.51B(+2.1%) |
Mar 2024 | - | $11.87B(+3.4%) | $45.53B(+1.2%) |
Dec 2023 | $45.01B(-2.5%) | $11.48B(+4.7%) | $45.01B(+0.2%) |
Sep 2023 | - | $10.97B(-2.3%) | $44.94B(-0.6%) |
Jun 2023 | - | $11.23B(-1.0%) | $45.19B(-1.4%) |
Mar 2023 | - | $11.34B(-0.6%) | $45.85B(-0.7%) |
Dec 2022 | $46.16B(-0.5%) | $11.41B(+1.7%) | $46.16B(-1.2%) |
Sep 2022 | - | $11.22B(-5.6%) | $46.74B(-0.9%) |
Jun 2022 | - | $11.89B(+2.1%) | $47.14B(+0.4%) |
Mar 2022 | - | $11.65B(-2.8%) | $46.96B(+1.2%) |
Dec 2021 | $46.38B(+9.1%) | $11.98B(+3.1%) | $46.38B(+2.0%) |
Sep 2021 | - | $11.62B(-0.7%) | $45.47B(+2.4%) |
Jun 2021 | - | $11.70B(+5.7%) | $44.38B(+3.7%) |
Mar 2021 | - | $11.07B(+0.0%) | $42.81B(+0.7%) |
Dec 2020 | $42.52B(+62.6%) | $11.07B(+5.0%) | $42.52B(+7.9%) |
Sep 2020 | - | $10.54B(+4.1%) | $39.40B(+13.0%) |
Jun 2020 | - | $10.13B(-6.0%) | $34.86B(+12.4%) |
Mar 2020 | - | $10.78B(+35.7%) | $31.01B(+18.6%) |
Dec 2019 | $26.14B(+15.9%) | $7.95B(+32.3%) | $26.14B(+8.2%) |
Sep 2019 | - | $6.01B(-4.2%) | $24.17B(+1.3%) |
Jun 2019 | - | $6.27B(+6.0%) | $23.86B(+2.4%) |
Mar 2019 | - | $5.92B(-0.9%) | $23.29B(+3.2%) |
Dec 2018 | $22.56B(+8.6%) | $5.97B(+5.0%) | $22.56B(+2.4%) |
Sep 2018 | - | $5.69B(-0.2%) | $22.04B(+2.0%) |
Jun 2018 | - | $5.70B(+9.8%) | $21.60B(+2.7%) |
Mar 2018 | - | $5.19B(-4.7%) | $21.04B(+1.3%) |
Dec 2017 | $20.78B(+6.9%) | $5.45B(+3.7%) | $20.78B(+1.0%) |
Sep 2017 | - | $5.25B(+2.1%) | $20.57B(+1.6%) |
Jun 2017 | - | $5.14B(+4.4%) | $20.24B(+1.4%) |
Mar 2017 | - | $4.93B(-6.0%) | $19.96B(+2.8%) |
Dec 2016 | $19.43B(+17.3%) | $5.24B(+6.5%) | $19.43B(+5.2%) |
Sep 2016 | - | $4.92B(+1.0%) | $18.47B(+4.8%) |
Jun 2016 | - | $4.87B(+10.9%) | $17.62B(+4.2%) |
Mar 2016 | - | $4.39B(+2.4%) | $16.91B(+2.1%) |
Dec 2015 | $16.56B(+4.3%) | $4.29B(+5.4%) | $16.56B(+0.2%) |
Sep 2015 | - | $4.07B(-2.3%) | $16.53B(+0.9%) |
Jun 2015 | - | $4.16B(+3.0%) | $16.38B(+1.7%) |
Mar 2015 | - | $4.04B(-5.1%) | $16.11B(+1.4%) |
Dec 2014 | $15.88B(-3.1%) | $4.26B(+8.6%) | $15.88B(-1.1%) |
Sep 2014 | - | $3.92B(+0.8%) | $16.06B(-0.9%) |
Jun 2014 | - | $3.89B(+2.0%) | $16.21B(-1.0%) |
Mar 2014 | - | $3.81B(-14.2%) | $16.36B(-0.1%) |
Dec 2013 | $16.39B(-7.0%) | $4.44B(+9.2%) | $16.39B(+1.5%) |
Sep 2013 | - | $4.07B(+0.4%) | $16.14B(+2.1%) |
Jun 2013 | - | $4.05B(+5.7%) | $15.81B(-2.4%) |
Mar 2013 | - | $3.83B(-8.6%) | $16.20B(-8.1%) |
Dec 2012 | $17.62B(-17.1%) | $4.19B(+12.2%) | $17.62B(-6.7%) |
Sep 2012 | - | $3.74B(-15.9%) | $18.88B(-7.9%) |
Jun 2012 | - | $4.44B(-15.4%) | $20.49B(-4.6%) |
Mar 2012 | - | $5.25B(-3.7%) | $21.48B(+1.1%) |
Dec 2011 | $21.24B(+9.0%) | $5.45B(+2.0%) | $21.24B(+1.6%) |
Sep 2011 | - | $5.34B(-1.6%) | $20.90B(+2.7%) |
Jun 2011 | - | $5.43B(+8.4%) | $20.35B(+3.4%) |
Mar 2011 | - | $5.01B(-2.0%) | $19.69B(+1.0%) |
Dec 2010 | $19.48B(+3.6%) | $5.11B(+6.5%) | $19.48B(+0.4%) |
Sep 2010 | - | $4.80B(+0.6%) | $19.41B(+0.1%) |
Jun 2010 | - | $4.77B(-0.8%) | $19.40B(+0.5%) |
Mar 2010 | - | $4.81B(-4.5%) | $19.29B(+2.6%) |
Dec 2009 | $18.81B(+6.2%) | $5.03B(+5.1%) | $18.81B(+16.5%) |
Sep 2009 | - | $4.79B(+2.6%) | $16.14B(-2.8%) |
Jun 2009 | - | $4.67B(+7.9%) | $16.61B(-3.1%) |
Mar 2009 | - | $4.32B(+82.6%) | $17.15B(-3.2%) |
Dec 2008 | $17.71B(-8.4%) | $2.37B(-54.9%) | $17.71B(-17.8%) |
Sep 2008 | - | $5.25B(+1.0%) | $21.56B(+3.1%) |
Jun 2008 | - | $5.20B(+6.4%) | $20.91B(+3.6%) |
Mar 2008 | - | $4.89B(-21.3%) | $20.18B(+2.9%) |
Dec 2007 | $19.35B(+12.1%) | $6.21B(+35.0%) | $19.60B(+15.7%) |
Sep 2007 | - | $4.60B(+2.9%) | $16.94B(+2.7%) |
Jun 2007 | - | $4.47B(+3.6%) | $16.50B(-2.4%) |
Mar 2007 | - | $4.32B(+21.4%) | $16.90B(-2.1%) |
Dec 2006 | $17.26B(-7.3%) | $3.56B(-14.4%) | $17.26B(-4.8%) |
Sep 2006 | - | $4.15B(-14.7%) | $18.12B(-3.3%) |
Jun 2006 | - | $4.87B(+4.2%) | $18.73B(-0.1%) |
Mar 2006 | - | $4.68B(+5.9%) | $18.75B(+0.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2005 | $18.61B(-4.0%) | $4.42B(-7.3%) | $18.61B(-3.8%) |
Sep 2005 | - | $4.77B(-2.5%) | $19.34B(-0.1%) |
Jun 2005 | - | $4.89B(+7.9%) | $19.36B(+0.4%) |
Mar 2005 | - | $4.53B(-12.1%) | $19.29B(-0.5%) |
Dec 2004 | $19.38B(+3.9%) | $5.16B(+7.9%) | $19.38B(+9.8%) |
Sep 2004 | - | $4.78B(-0.9%) | $17.65B(-3.3%) |
Jun 2004 | - | $4.82B(+4.2%) | $18.24B(-1.7%) |
Mar 2004 | - | $4.63B(+35.1%) | $18.55B(-0.5%) |
Dec 2003 | $18.65B(+3.0%) | $3.42B(-36.3%) | $18.65B(-6.8%) |
Sep 2003 | - | $5.37B(+4.7%) | $20.01B(+4.4%) |
Jun 2003 | - | $5.13B(+8.5%) | $19.18B(+5.5%) |
Mar 2003 | - | $4.73B(-1.1%) | $18.17B(+0.4%) |
Dec 2002 | $18.11B(+0.7%) | $4.78B(+5.4%) | $18.11B(+0.9%) |
Sep 2002 | - | $4.54B(+9.9%) | $17.94B(+0.2%) |
Jun 2002 | - | $4.13B(-11.5%) | $17.90B(-3.1%) |
Mar 2002 | - | $4.66B(+1.1%) | $18.48B(-0.2%) |
Dec 2001 | $17.99B(-1.3%) | $4.61B(+2.5%) | $18.51B(-0.9%) |
Sep 2001 | - | $4.50B(-4.4%) | $18.68B(-0.3%) |
Jun 2001 | - | $4.71B(+0.4%) | $18.75B(-2.9%) |
Mar 2001 | - | $4.69B(-2.0%) | $19.31B(+1.2%) |
Dec 2000 | $18.22B(+7.9%) | $4.78B(+4.8%) | $19.07B(+1.0%) |
Sep 2000 | - | $4.56B(-13.5%) | $18.88B(+2.0%) |
Jun 2000 | - | $5.28B(+18.5%) | $18.51B(+2.0%) |
Mar 2000 | - | $4.45B(-3.0%) | $18.15B(-2.2%) |
Dec 1999 | $16.88B(+12.1%) | $4.59B(+9.5%) | $18.55B(+18.7%) |
Sep 1999 | - | $4.19B(-14.8%) | $15.63B(-2.1%) |
Jun 1999 | - | $4.92B(+1.4%) | $15.96B(+3.2%) |
Mar 1999 | - | $4.85B(+192.1%) | $15.47B(+2.7%) |
Dec 1998 | $15.06B(-9.8%) | $1.66B(-63.3%) | $15.06B(-15.6%) |
Sep 1998 | - | $4.52B(+2.1%) | $17.84B(+2.1%) |
Jun 1998 | - | $4.43B(-0.4%) | $17.47B(+2.1%) |
Mar 1998 | - | $4.45B(+0.1%) | $17.10B(+2.4%) |
Dec 1997 | $16.70B(+10.9%) | $4.44B(+7.0%) | $16.70B(+3.0%) |
Sep 1997 | - | $4.15B(+2.1%) | $16.21B(+2.6%) |
Jun 1997 | - | $4.06B(+0.5%) | $15.81B(+2.4%) |
Mar 1997 | - | $4.04B(+2.3%) | $15.44B(+2.5%) |
Dec 1996 | $15.06B(+9.4%) | $3.96B(+5.6%) | $15.06B(+2.4%) |
Sep 1996 | - | $3.75B(+1.3%) | $14.72B(+2.3%) |
Jun 1996 | - | $3.70B(+0.7%) | $14.39B(+1.8%) |
Mar 1996 | - | $3.67B(+1.7%) | $14.13B(+2.7%) |
Dec 1995 | $13.77B(+14.9%) | $3.61B(+5.7%) | $13.77B(+2.7%) |
Sep 1995 | - | $3.41B(-0.9%) | $13.41B(+3.7%) |
Jun 1995 | - | $3.44B(+4.4%) | $12.93B(+3.8%) |
Mar 1995 | - | $3.30B(+1.6%) | $12.45B(+3.9%) |
Dec 1994 | $11.98B(+5.0%) | $3.25B(+10.8%) | $11.98B(+2.2%) |
Sep 1994 | - | $2.93B(-1.3%) | $11.73B(+0.6%) |
Jun 1994 | - | $2.97B(+4.8%) | $11.66B(+1.5%) |
Mar 1994 | - | $2.83B(-5.3%) | $11.49B(+0.7%) |
Dec 1993 | $11.41B(+2.3%) | $2.99B(+4.6%) | $11.41B(+5.6%) |
Sep 1993 | - | $2.86B(+2.1%) | $10.81B(-2.2%) |
Jun 1993 | - | $2.80B(+1.7%) | $11.05B(-0.7%) |
Mar 1993 | - | $2.75B(+15.3%) | $11.13B(-0.3%) |
Dec 1992 | $11.16B(-0.0%) | $2.39B(-23.0%) | $11.16B(-4.7%) |
Sep 1992 | - | $3.10B(+7.7%) | $11.70B(+3.0%) |
Jun 1992 | - | $2.88B(+3.5%) | $11.36B(+1.3%) |
Mar 1992 | - | $2.78B(-5.2%) | $11.21B(+0.4%) |
Dec 1991 | $11.16B(+8.3%) | $2.94B(+6.5%) | $11.16B(+1.8%) |
Sep 1991 | - | $2.76B(+1.0%) | $10.96B(+1.2%) |
Jun 1991 | - | $2.73B(-0.2%) | $10.82B(+2.3%) |
Mar 1991 | - | $2.73B(-0.0%) | $10.58B(+2.7%) |
Dec 1990 | $10.30B(+12.1%) | $2.74B(+4.3%) | $10.30B(+3.8%) |
Sep 1990 | - | $2.62B(+5.6%) | $9.92B(+3.1%) |
Jun 1990 | - | $2.48B(+1.1%) | $9.62B(+2.6%) |
Mar 1990 | - | $2.46B(+4.2%) | $9.38B(+2.1%) |
Dec 1989 | $9.19B(+7.4%) | $2.36B(+1.7%) | $9.19B(+2.4%) |
Sep 1989 | - | $2.32B(+3.4%) | $8.97B(+1.4%) |
Jun 1989 | - | $2.24B(-0.9%) | $8.85B(+1.6%) |
Mar 1989 | - | $2.27B(+5.6%) | $8.71B(+1.7%) |
Dec 1988 | $8.56B(+13.2%) | $2.14B(-2.4%) | $8.56B(+3.1%) |
Sep 1988 | - | $2.20B(+4.5%) | $8.30B(+3.8%) |
Jun 1988 | - | $2.10B(-0.8%) | $8.00B(+2.7%) |
Mar 1988 | - | $2.12B(+12.0%) | $7.79B(+3.0%) |
Dec 1987 | $7.56B | $1.89B(0.0%) | $7.56B(+33.3%) |
Sep 1987 | - | $1.89B(0.0%) | $5.67B(+50.0%) |
Jun 1987 | - | $1.89B(0.0%) | $3.78B(+100.0%) |
Mar 1987 | - | $1.89B | $1.89B |
FAQ
- What is Bristol-Myers Squibb annual revenue?
- What is the all time high annual revenue for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual revenue year-on-year change?
- What is Bristol-Myers Squibb quarterly revenue?
- What is the all time high quarterly revenue for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly revenue year-on-year change?
- What is Bristol-Myers Squibb TTM revenue?
- What is the all time high TTM revenue for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM revenue year-on-year change?
What is Bristol-Myers Squibb annual revenue?
The current annual revenue of BMY is $48.30B
What is the all time high annual revenue for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual revenue is $48.30B
What is Bristol-Myers Squibb annual revenue year-on-year change?
Over the past year, BMY annual revenue has changed by +$3.29B (+7.32%)
What is Bristol-Myers Squibb quarterly revenue?
The current quarterly revenue of BMY is $12.34B
What is the all time high quarterly revenue for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly revenue is $12.34B
What is Bristol-Myers Squibb quarterly revenue year-on-year change?
Over the past year, BMY quarterly revenue has changed by +$865.00M (+7.54%)
What is Bristol-Myers Squibb TTM revenue?
The current TTM revenue of BMY is $48.30B
What is the all time high TTM revenue for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM revenue is $48.30B
What is Bristol-Myers Squibb TTM revenue year-on-year change?
Over the past year, BMY TTM revenue has changed by +$3.29B (+7.32%)